According to FINSMES, Genetesis, a cardiac imaging company, raised $9.2M in Series B financing. The round included strategic investments from TDK Ventures and an undisclosed Fortune 500 global healthcare company, as well as return investors CincyTech, Ohio Innovation Fund, and Mark Cuban.

Genetesis is a medical device company based in Mason, Ohio creating and developing integrated biomagnetic solutions to improve patients' health, outcomes, and quality of life.